image credit: Adobe Stock

Hovione and H&T Presspart Extend Partnership for Dry Powder Inhalation Formulation Delivery

May 4, 2023


Hovione and H&T Presspart have partnered to advance the development of Presspart’s Sunriser Capsule-based Dry Powder Inhaler platform. The companies plan to work together to develop the Sunriser Dry Powder Inhaler, which is flexible enough to address the challenges of carrier-based and spray-dried engineered formulations, according to the press release.

A part of the development agreement finds Hovione being an exclusive partner with Presspart to use the Sunriser device in engineered formulations for dry powder inhalation. Additionally, Presspart will still be responsible for the manufacturing of the Sunriser device.

Read More on Biopharm International